Today marks the official launch of the American Alliance for Biomanufacturing (AAB), a new coalition of industry leaders committed to advancing U.S. leadership in biomanufacturing innovation, competitiveness, and resilience.

‍

The Alliance brings together essential stakeholders from across the industrial biomanufacturing ecosystem to address critical challenges and opportunities in a rapidly evolving sector that is increasingly vital to American economic and national security, and public health.

‍

The formation of AAB comes at a pivotal moment, with the National Security Commission on Emerging Biotechnology (NSCEB) calling for a coordinated, whole-of-government strategy to ensure U.S. global leadership in industrial biomanufacturing.

‍

Ajikumar "Aji" Parayil, Chief Executive Officer, Manus:

“Industrial biomanufacturing is no longer just a scientific opportunity – it is a strategic imperative. The Alliance is a focused, execution-oriented step toward a much-needed national strategy that aligns innovation with job creation, supply chain resilience, and global competitiveness. At Manus, we deliver bioalternative production at scale in the U.S. – fostering sustainable economic growth, revitalizing rural communities, and creating real-world impact.”

‍

Biomanufacturing – which utilizes biological systems to manufacture products spanning sectors as diverse as energy, defense, agriculture, chemicals, ingredients, sweeteners, materials, fabrics, and nutrition – is a $20B global industry poised to grow exponentially. In its report, the NSCEB implored U.S. policymakers get behind the development of a robust U.S. bio-industrial economy: “the choice is stark: do nothing and accept defeat or act swiftly and give America a fighting chance.”

‍

“Biomanufacturing technologies are advancing, enabling the production of stickier resins, better fertilizers, healthier ingredients, more durable nylon, and sustainable plastics," says Brooke Coleman, Executive Director of the Alliance. "By working together, and recognizing global realities, we can ensure that the United States maintains its competitive edge in developing and scaling the biological products and processes that will define the 21^st century economy."

‍

The Alliance will focus on two key objectives: (1) supercharging U.S. demand for bio-based products and technologies; and (2) ensuring market readiness for existing and novel bioproducts. It will also seek to strengthen domestic supply chains for biological materials, equipment, and technologies to enhance U.S. global competitiveness.

‍

For more information about the American Alliance for Biomanufacturing, visit www.aabio.org.